Proapoptotic Activity of a Monomeric Smac Mimetic on Human Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis

Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis

(2013) Iris Navarro-Millán et al.   CURRENT OPINION IN RHEUMATOLOGY

Small molecular compounds in development for rheumatoid arthritis

(2013) Ronald F. van Vollenhoven   CURRENT OPINION IN RHEUMATOLOGY

Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents

(2012) Aldo Bianchi et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors

(2012) Nunzio Bottini et al.   Nature Reviews Rheumatology

Epirubicin potentiates recombinant adeno-associated virus type 2/5-mediated TRAIL expression in fibroblast-like synoviocytes and augments the antiarthritic effects of rAAV2/5-TRAIL

(2011) Juan Shi et al.   ARTHRITIS AND RHEUMATISM

The Pathogenesis of Rheumatoid Arthritis

(2011) Iain B. McInnes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cell death in rheumatoid arthritis

(2009) Adelheid Korb et al.   APOPTOSIS

Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy

(2009) Pierfausto Seneci et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis

(2009) Beatrix Bartok et al.   IMMUNOLOGICAL REVIEWS

Role of Smac/DIABLO in cancer progression

(2008) Gustavo Martinez-Ruiz et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH